More tools:Markets·Screener·Research·Chat

IperionX Limited American Depositary Share (IPX) Financial Statements

IperionX Limited American Depositary Share
SIC 1241 · GOLD AND SILVER ORES
FIGI BBG0188WZ520
XNAS · usd
22.37▲ 0.62 (2.85%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close21.75
Day's Range21.90 – 23.07
52-Week Range20.05 – 61.45
Volume176.7K
Avg Volume246.3K
Share Statistics
Shares Outstanding
Employees70
ExchangeXNAS
Listed2022-06-21
Share count as of June 30, 2025
Loading Income Statement…
Key questions about IperionX Limited American Depositary Share (IPX)
What is IperionX Limited American Depositary Share's Market Cap?
IperionX Limited American Depositary Share's Market Cap is $7.2B, based on as-reported figures from SEC (XBRL) filings.
What is IperionX Limited American Depositary Share's Enterprise Value?
IperionX Limited American Depositary Share's Enterprise Value is $7.1B, based on as-reported figures from SEC (XBRL) filings.
What is IperionX Limited American Depositary Share's Net Income (TTM)?
IperionX Limited American Depositary Share's Net Income (TTM) is -$53.9M, based on as-reported figures from SEC (XBRL) filings.
What is IperionX Limited American Depositary Share's Diluted EPS (TTM)?
IperionX Limited American Depositary Share's Diluted EPS (TTM) is -0.17, based on as-reported figures from SEC (XBRL) filings.
What is IperionX Limited American Depositary Share's Net Debt?
IperionX Limited American Depositary Share's Net Debt is -$61.3M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This statement has no quarterly history yet.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022
Continuing operations
Research and development costs
Exploration and evaluation expenses
Corporate and administrative expenses
Business development expenses
Share-based payment expenses
Finance income
Finance costs
Other income and expenses
Loss before income tax
Tax expense (income)
Loss for the year
Loss attributable to shareholders of IperionX Limited
Items that may be reclassified subsequently to profit or loss:
Exchange differences arising on translation into presentation currency
Other comprehensive loss for the year, net of tax
Total comprehensive loss for the year
Total comprehensive loss attributable to shareholders of IperionX Limited
Basic loss per share (US$ per share)
Diluted loss per share (US$ per share)